By Dean Seal
Astrana Health has agreed to buy the businesses and assets of Prospect Health for $745 million and the assumption of certain liabilities.
The healthcare company said Friday that it is acquiring the full Prospect Health System, which includes Prospect's licensed healthcare service plan in California and medical groups in California, Texas, Arizona and Rhode Island.
Astrana is also taking on Prospect's management service organization, the RightRx pharmacy and Alta Newport Hospital, an acute care hospital in California better known as Foothill Regional. Prospect is expected to generate revenue of about $1.2 billion in 2024, along with about $81 million in adjusted Ebitda.
Astrana is funding the acquisition with cash on hand and a $1.1 billion bridge loan from Truist Bank and J.P. Morgan.
The deal is expected to close in the middle of next year, pending regulatory approval.
Prospect is a tenant of Medical Properties Trust, which said Friday that the Astrana acquisition includes the assumption of certain liabilities but didn't go into further detail.
The real estate investment trust said it stands to receive about $200 million in proceeds from the Astrana acquisition, with most of that coming in the first half of 2025 and about $50 million expected by 2027.
Medical Properties Trust reported third-quarter results on Thursday and said Prospect hadn't paid cash rent related to six California properties.
Prospect was attempting to exit multiple east coast markets that were generating losses and impacting overall liquidity, including in Pennsylvania and Rhode Island, the real estate investment trust said.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
November 08, 2024 08:50 ET (13:50 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。